Bilenker Joshua H.'s Form 4 filing
Sana Biotechnology, Inc. (SANA) · filed Feb 17, 2023
- Accession no.
- 0001562180-23-001518
- Filed
- Feb 17, 2023
- Trade date
- Feb 3, 2021
- Filing delay
- 744 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $500.0K. It was filed 744 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bilenker Joshua H.CIK 0001612312 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2021 | Common Stock | PPurchaseAcquired | +20,000 | $25.00 | +$500,000 | 20,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.